As anticipated, the immunized mice developed TIF1γ-specific T cells and anti-human and murine TIF1γ antibodies, resulting in myositis in the hamstrings and quadriceps two weeks after the last immunization. The gene discussed is TRIM33; the disease is myositis disease.